BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2001
View Archived Issues
VEGF receptor tyrosine kinase inhibitor blocks proliferation, migration of multiple myeloma cells
Read More
ASH news: PD-180970 blocks activation of Stat5 and inhibits CML cell growth
Read More
Oral HDAC inhibitor MS-275 induces cell cycle arrest, apoptosis and differentiation in AML cells
Read More
Clinical efficacy and safety of zosuquidar as a modulator of P-glycoprotein in leukemia and lymphoma
Read More
OSI R&D progress highlighted at inaugural research day
Read More
Studies at Dana-Farber point to usefulness of beta-lapachone in multiple myeloma
Read More
Clinical trials of milnacipran in FMS expected to begin in 2002
Read More
Medivir designates candidate drug in HIV/NNRTI research program
Read More
Telomerase inhibitor collaboration established by Geron and Ribozyme
Read More
Encouraging results reported from phase IIa trial of XTL-001 in chronic hepatitis B patients
Read More
GSK and Roche to codevelop and copromote ibandronate
Read More
PDL's humanized Zamyl MAb safe and active in refractory/relapsed AML
Read More
FDA advisory committee recommends Gliadel Wafer for newly diagnosed malignant glioma
Read More
Arixtra receives FDA approval
Read More
Phase II trial of Avicine cancer vaccine shows survival benefit
Read More
Hexvix cleared for phase III trials in the U.S.
Read More
Millennium and Cor Therapeutics announce merger plans
Read More
Clofarex designated an orphan drug for leukemia; encouraging clinical findings reported
Read More
Novel macrocyclic peptidomimetic antitumor agents in development at U. of Pennsylvania
Read More
Trio of pharmaceutical companies jointly design potential agents for bone disorders
Read More
Novel compounds for lipid disorders emerge from R&D at Novartis
Read More
DuPont researchers identify lactam inhibitors of Abeta production
Read More
U.S. academic researchers claim bile acid-containing prodrugs
Read More
Preparation and use of CXCR2 receptor modulators disclosed by AstraZeneca
Read More
